Cramer’s lightning round: BioXcel Therapeutics may be home run or nothing

Cramer’s lightning round: BioXcel Therapeutics may be home run or nothing


Veru Inc: “The test for [the company’s Covid treatment pill] … The FDA staff didn’t seem to like it.”

Cramer's lightning round: BioXcel Therapeutics may be home run or nothing

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Fewer burritos, more bargains: Consumers flash holiday warning signs
Business

Fewer burritos, more bargains: Consumers flash holiday warning signs

Shoppers walk through Manhattan on Nov. 7, 2025, in New York City. Spencer Platt | Getty Images High-income consumers are trading down, Gen Z is spending less, and low-income shoppers are still struggling, according to many consumer companies that shared their latest quarterly results in recent weeks. Those trends may not bode well for the […]

Read More
JPMorgan Chase wins fight with fintech firms over fees to access customer data
Business

JPMorgan Chase wins fight with fintech firms over fees to access customer data

An exterior view of the new JPMorgan Chase global headquarters building at 270 Park Avenue on Nov. 13, 2025 in New York City. Angela Weiss | AFP | Getty Images JPMorgan Chase has secured deals ensuring it will get paid by the fintech firms responsible for nearly all the data requests made by third-party apps […]

Read More
Walmart CEO Doug McMillon to retire in January after nearly 12 years leading retailer
Business

Walmart CEO Doug McMillon to retire in January after nearly 12 years leading retailer

Walmart CEO Doug McMillon is retiring early next year, the company said Friday in a filing. The longtime CEO will be succeeded by John Furner, the Walmart U.S. CEO, on Feb. 1, according to the filing. McMillon, who stepped into the top role at Walmart in February 2014, will officially retire as of Jan. 31. […]

Read More